Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...

The FDA clearance enables the commercial use of VitaSmart (TM) for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, providing a clear, ...

LOS ANGELES, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The Global Perfusion Systems Market Size accounted for USD 1.3 Billion in 2022 and is projected to achieve a market size of USD 1.9 Billion by 2032 ...

REUP technique in the works for DCD heart procurement without need for organ reanimation ...

Therapeutic hypothermia of donors didn't preserve kidney function as well as machine perfusion of the organ during cold storage, a randomized trial found. Compared with kidneys pumped with a ...

Potential for improved product quality and cost/time savings is reviving interest in perfusion technology. Tuomas Kujansuu/E+/Getty Images Perfusion technology was first introduced in the late 1980s ...

Please provide your email address to receive an email when new articles are posted on . Tissue perfusion pressure may be a new target for BP optimization in circulatory shock. TPP was significantly ...

New Atlas reports that scientists have a new way to keep livers alive for a week—and maybe to bring unfit livers back to life. The solution is a machine that mimics human body functions, which lets ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...